OppenheimerFunds’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

OppenheimerFunds’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-11,539	Closed	-$129K	–	1913
2017 Q3	$129K	Sell	11,539 -796	-6%	-$8.78K	﹤0.01%	1838
2017 Q2	$135K	Sell	12,335 -974	-7%	-$9.74K	﹤0.01%	1840
2017 Q1	$131K	Buy	13,309 +3,065	+30%	+$30.6K	﹤0.01%	1846
2016 Q4	$111K	Buy	+10,244	New	+$102K	﹤0.01%	1770

OppenheimerFunds's SCLN Position: Q4 2017 in Review

OppenheimerFunds sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 11,539 shares — an estimated $129K sold.

OppenheimerFunds first reported a position in SCLN in Q4 2016 and held it in 4 quarters. The position peaked at $135K in Q2 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

OppenheimerFunds reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
OppenheimerFunds sold 11,539 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $129K.
OppenheimerFunds first reported a position in Sciclone Pharmaceuticals Inc in Q4 2016 and held it in 4 quarters.
OppenheimerFunds's Sciclone Pharmaceuticals Inc position peaked at $135K in Q2 2017.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on OppenheimerFunds's 13F filing for Q4 2017, filed 12 Feb 2018.